In the shadow of this excitement, the 3rd Cell Therapy for Autoimmune Disease Summit returns to Philadelphia this December as ...

Lumos has generally not been secretive about its plans to branch into regulated medical devices-- it launched a new division called Lumosity DTx in 2021. However, the company has not publicised the ...

Stada chief executive Peter Goldschmidt has said that the company will go for an initial public offering (IPO) in the coming months "provided the general conditions are right," according to Reuters, ...

Eli Lilly has paused shipments of its type 2 diabetes and weight loss therapy Mounjaro to the UK, ahead of a price increase next month that has reportedly led patients to start stockpiling the drug.

An attempt by Health and Human Services (HHS) Secretary Robert F Kennedy Jr to oust Susan Monarez as director of the CDC has run into a snag – she is refusing to step down.

Armed with new survival data from the monarchE trial of CDK4/6 inhibitor Verzenio, Eli Lilly looks set to cement the drug's place in the treatment of early-stage breast cancer, and keep its nose in ...

The 2nd Cell & Gene Therapy Regulatory Affairs Summit (December 2-4, Washington, D.C.) is the only industry-led event ...

To begin, let’s consider a cornerstone of European patent law: Article 53 (c) of the European Patent Convention (EPC). This ...

The EU has given Gilead the green light to market its twice-yearly pre-exposure prophylaxis (PrEP) product lenacapavir, which ...

Roche's Genentech unit has started work on a $700 million manufacturing facility in North Carolina, part of a promised $50 ...

More than 80% of cardiac care professionals think AI can help tackle major issues facing teams, including lengthening delays ...

Nykode will boost its spending on its third major platform – designed to induce tolerance in autoimmune diseases – but a ...